More articles from Molecular and Cellular Biology, Genetics

Abstract LB-268: Rate of temporal citrate efflux from malignant mitochondria predicts clinical aggressiveness in breast tumors
Andre Koit, Natalja Timohhina, Vladimir Chekulayev, Vahur Valvere, Tuuli Kaambre

Cancer Research Jul 2017, 77 (13 Supplement) LB-268; DOI: 10.1158/1538-7445.AM2017-LB-268
Abstract LB-328: Mir-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
Ann-Joy Cheng, Ya-Ching Lu, Joseph T. Chang

Cancer Research Jul 2017, 77 (13 Supplement) LB-328; DOI: 10.1158/1538-7445.AM2017-LB-328
Abstract LB-331: Advanced DNA-gold nanoprobe-based direct and sensitive quantification of novel microRNAs in prostate cancer
Prakash Kshirsagar, Satyanarayana Rachagani, Parthasarathy Seshacharyulu, Sakthivel Muniyan, Ram Mahato, Surinder K. Batra, Maneesh Jain

Cancer Research Jul 2017, 77 (13 Supplement) LB-331; DOI: 10.1158/1538-7445.AM2017-LB-331
Abstract LB-269: PFKP/PFKFB3 modulate metabolic switch and chemoresistance to cisplatin in ovarian cancer
Jingjing Wang, Michelle KY Siu, Yuxin Jiang, Thomas HY Leung, Hextan YS NGAN, Annie NY Cheung, Karen KL Chan

Cancer Research Jul 2017, 77 (13 Supplement) LB-269; DOI: 10.1158/1538-7445.AM2017-LB-269
Abstract LB-276: Characterizing tumorigenesis of ovarian cancer across metastatic tumors and circulating, cell-free DNA
Ashley Wood, Sukhinder Sandhu, Matthew Dashkoff, Olga Camacho-Vanegas, Laurie Kurihara, Timothy Harkins, John Martignetti, Vladimir Makarov, Peter Dottino

Cancer Research Jul 2017, 77 (13 Supplement) LB-276; DOI: 10.1158/1538-7445.AM2017-LB-276
Abstract DDT01-01: The discovery and preclinical characterization of AMG 176: A first-in-class Mcl-1 inhibitor in clinical development for multiple myeloma
Paul E. Hughes

Cancer Research Jul 2017, 77 (13 Supplement) DDT01-01; DOI: 10.1158/1538-7445.AM2017-DDT01-01
Abstract LB-265: 5’ gap-mediated long patch base excision repair
Jordan Woodrick, Sharon Camacho, Swetha Parvathaneni, Sudha Sharma, Rabindra Roy

Cancer Research Jul 2017, 77 (13 Supplement) LB-265; DOI: 10.1158/1538-7445.AM2017-LB-265
Abstract LB-275: Precise enumeration of cell-free DNA from patient-derived cell lines
Sean Hennigan, Shana Trostel, Adam G. Sowalsky

Cancer Research Jul 2017, 77 (13 Supplement) LB-275; DOI: 10.1158/1538-7445.AM2017-LB-275
Abstract LB-280: The landscape of somatic microsatellite indels across cancer: detection and identification of driver events
Yosef E. Maruvka, Kent W. Mouw, Rosa Karlic, Rasanna Parasuraman, Atanas Kamburov, Paz Polak, Nicholas J. Haradhvala, Julian M. Hess, Esther Rheinbay, Yehuda Brody, Lior Z. Braunstein, Alan D’Andrea, Michael S. Lawrence, Adam Bass, Andre Bernards, Franziska Michor, Gad Getz

Cancer Research Jul 2017, 77 (13 Supplement) LB-280; DOI: 10.1158/1538-7445.AM2017-LB-280
Abstract DDT01-02: AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancers
Alexander W. Hird, J. Paul Secrist, Ammar Adam, Matthew A. Belmonte, Eric Gangl, Frank Gibbons, David Hargreaves, Jeffrey W. Johannes, Stephen L. Kazmirski, Jason G. Kettle, Stephen E. Kurtz, Michelle L. Lamb, Martin J. Packer, Bo Peng, Craig R. Stewart, Jeffrey W. Tyner, Wenzhan Yang, Qing Ye, XiaoLan Zheng, Edwin A. Clark

Cancer Research Jul 2017, 77 (13 Supplement) DDT01-02; DOI: 10.1158/1538-7445.AM2017-DDT01-02

Main menu

User menu

Search

More articles from Molecular and Cellular Biology, Genetics

Pages

Articles

Info for

About Cancer Research